Trofinetide Recruiting Phase 3 Trials for Rett's Syndrome Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04181723Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDERâ„¢)